Carboline derivative serving as bromodomain inhibitor
US10428071B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 9, 2017 |
| Grant date | Oct 1, 2019 |
| Priority date | — |
| Expiry date | Jan 9, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed in the present invention is a carboline derivative serving as an bromodomain inhibitor. The carboline derivative in the present invention can be used as an bromodomain inhibitor, and can provide a method and a pharmaceutical composition for controlling diseases intervened by a bromodomain protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.